Fig. 14. Impact of MPS-based models on drug discovery screening strategies.
A model of how to transform drug discovery screening strategies by including disease mimicking multi-organ system approaches and tools is proposed. The model can be used to analyze and unravel disease mechanisms and define treatment interventions.